HAEMONETICS CORP Quarterly Research and Development Expense in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
Summary
Haemonetics Corp quarterly/annual Research and Development Expense history and growth rate from Q2 2010 to Q3 2024.
  • Haemonetics Corp Research and Development Expense for the quarter ending September 28, 2024 was $16.5M, a 30.5% increase year-over-year.
  • Haemonetics Corp Research and Development Expense for the twelve months ending September 28, 2024 was $60.1M, a 12% increase year-over-year.
  • Haemonetics Corp annual Research and Development Expense for 2023 was $54.4M, a 8.59% increase from 2022.
  • Haemonetics Corp annual Research and Development Expense for 2022 was $50.1M, a 7.12% increase from 2021.
  • Haemonetics Corp annual Research and Development Expense for 2021 was $46.8M, a 42.4% increase from 2020.
Research and Development Expense, Trailing 12 Months (USD)
Research and Development Expense, Quarterly (USD)
Research and Development Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $60.1M $16.5M +$3.87M +30.5% Jun 30, 2024 Sep 28, 2024 10-Q 2024-11-07
Q2 2024 $56.2M $14.4M +$1.8M +14.2% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-08
Q1 2024 $54.4M $15.9M +$213K +1.36% Dec 31, 2023 Mar 30, 2024 10-K 2024-05-20
Q4 2023 $54.2M $13.3M +$576K +4.54% Oct 1, 2023 Dec 30, 2023 10-Q 2024-02-08
Q3 2023 $53.6M $12.7M +$1.77M +16.2% Jul 2, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $51.9M $12.6M +$1.75M +16% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-08
Q1 2023 $50.1M $15.6M +$2.43M +18.4% Jan 1, 2023 Apr 1, 2023 10-K 2024-05-20
Q4 2022 $47.7M $12.7M +$2.65M +26.4% Oct 2, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 $45M $10.9M +$43K +0.4% Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-02
Q2 2022 $45M $10.9M -$1.8M -14.2% Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-08
Q1 2022 $46.8M $13.2M +$2.37M +21.8% Jan 2, 2022 Apr 2, 2022 10-K 2024-05-20
Q4 2021 $44.4M $10M +$2.54M +33.8% Oct 3, 2021 Jan 1, 2022 10-Q 2023-02-07
Q3 2021 $41.9M $10.9M +$4.09M +60.5% Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-08
Q2 2021 $37.8M $12.7M +$4.95M +63.9% Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-10
Q1 2021 $32.9M $10.8M +$1.87M +20.8% Dec 27, 2020 Apr 3, 2021 10-K 2023-05-22
Q4 2020 $31M $7.5M +$501K +7.16% Sep 27, 2020 Dec 26, 2020 10-Q 2022-02-08
Q3 2020 $30.5M $6.76M -$659K -8.88% Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-09
Q2 2020 $31.1M $7.75M +$263K +3.51% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-11
Q1 2020 $30.9M $8.97M +$227K +2.6% Dec 29, 2019 Mar 28, 2020 10-K 2022-05-25
Q4 2019 $30.7M $7M -$1.98M -22% Sep 29, 2019 Dec 28, 2019 10-Q 2021-02-02
Q3 2019 $32.6M $7.42M -$1.16M -13.5% Jun 30, 2019 Sep 28, 2019 10-Q 2020-11-04
Q2 2019 $33.8M $7.49M -$1.92M -20.4% Mar 31, 2019 Jun 29, 2019 10-Q 2020-08-04
Q1 2019 $35.7M $8.75M -$2.34M -21.1% Dec 30, 2018 Mar 30, 2019 10-K 2021-05-26
Q4 2018 $38.1M $8.98M -$3.45M -27.8% Sep 30, 2018 Dec 29, 2018 10-Q 2020-02-04
Q3 2018 $41.5M $8.58M +$1.06M +14.1% Jul 1, 2018 Sep 29, 2018 10-Q 2019-11-01
Q2 2018 $40.4M $9.41M +$1.21M +14.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $39.2M $11.1M +$1.77M +18.9% Dec 31, 2017 Mar 31, 2018 10-K 2020-05-20
Q4 2017 $37.5M $12.4M +$3.97M +46.9% Oct 1, 2017 Dec 30, 2017 10-Q 2019-02-05
Q3 2017 $33.5M $7.52M -$815K -9.78% Jul 2, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $34.3M $8.19M -$3.24M -28.4% Apr 2, 2017 Jul 1, 2017 10-Q 2018-08-07
Q1 2017 $37.6M $9.32M -$1.83M -16.4% Jan 1, 2017 Apr 1, 2017 10-K 2019-05-22
Q4 2016 $39.4M $8.46M -$2.48M -22.7% Oct 2, 2016 Dec 31, 2016 10-Q 2018-02-06
Q3 2016 $41.9M $8.34M -$3.22M -27.8% Jul 3, 2016 Oct 1, 2016 10-Q 2017-11-07
Q2 2016 $45.1M $11.4M +$116K +1.03% Apr 3, 2016 Jul 2, 2016 10-Q 2017-08-07
Q1 2016 $45M $11.1M -$6.08M -35.3% Dec 27, 2015 Apr 2, 2016 10-K 2018-05-23
Q4 2015 $51M $10.9M +$299K +2.81% Sep 27, 2015 Dec 26, 2015 10-Q 2017-02-06
Q3 2015 $50.7M $11.6M +$615K +5.62% Jun 28, 2015 Sep 26, 2015 10-Q 2016-11-07
Q2 2015 $50.1M $11.3M -$4.06M -26.4% Mar 29, 2015 Jun 27, 2015 10-Q 2016-08-01
Q1 2015 $54.2M $17.2M +$3.39M +24.5% Dec 28, 2014 Mar 28, 2015 10-K 2017-05-24
Q4 2014 $50.8M $10.6M -$3.57M -25.1% Sep 28, 2014 Dec 27, 2014 10-Q 2016-02-02
Q3 2014 $54.4M $10.9M -$4.01M -26.8% Jun 29, 2014 Sep 27, 2014 10-Q 2015-11-04
Q2 2014 $58.4M $15.4M +$4.17M +37.2% Mar 30, 2014 Jun 28, 2014 10-Q 2015-07-30
Q1 2014 $54.2M $13.8M +$266K +1.96% Dec 29, 2013 Mar 29, 2014 10-K 2016-06-01
Q4 2013 $53.9M $14.2M +$3.62M +34.2% Sep 29, 2013 Dec 28, 2013 10-Q 2015-02-05
Q3 2013 $50.3M $14.9M +$4.12M +38% Jun 30, 2013 Sep 28, 2013 10-Q 2014-11-04
Q2 2013 $46.2M $11.2M +$1.8M +19.1% Mar 31, 2013 Jun 29, 2013 10-Q 2014-07-31
Q1 2013 $44.4M $13.6M +$4.96M +57.6% Dec 30, 2012 Mar 30, 2013 10-K 2015-05-22
Q4 2012 $39.4M $10.6M +$1.36M +14.7% Sep 30, 2012 Dec 29, 2012 10-Q 2014-01-30
Q3 2012 $38.1M $10.8M +$477K +4.61% Jul 1, 2012 Sep 29, 2012 10-Q 2013-10-30
Q2 2012 $37.6M $9.41M +$800K +9.29% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 $36.8M $8.61M -$176K -2% Jan 1, 2012 Mar 31, 2012 10-K 2014-05-22
Q4 2011 $37M $9.23M +$1.24M +15.5% Oct 2, 2011 Dec 31, 2011 10-Q 2013-02-01
Q3 2011 $35.7M $10.4M +$2.4M +30.1% Jul 3, 2011 Oct 1, 2011 10-Q 2012-11-07
Q2 2011 $33.3M $8.61M +$689K +8.7% Apr 3, 2011 Jul 2, 2011 10-Q 2012-08-08
Q1 2011 $32.7M $8.79M Jan 2, 2011 Apr 2, 2011 10-K 2013-05-20
Q4 2010 $8M Oct 3, 2010 Jan 1, 2011 10-Q 2012-02-06
Q3 2010 $7.95M Jul 4, 2010 Oct 2, 2010 10-Q 2011-11-03
Q2 2010 $7.92M Apr 4, 2010 Jul 3, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.